Comerica Bank’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-120
| Closed | -$1.09K | – | 3798 |
|
|
2025
Q2 | $1.09K | Hold |
120
| – | – | ﹤0.01% | 3573 |
|
|
2025
Q1 | $954 | Hold |
120
| – | – | ﹤0.01% | 3568 |
|
|
2024
Q4 | $652 | Buy |
120
+112
| +1,400% | +$685 | ﹤0.01% | 3594 |
|
|
2024
Q3 | $58 | Sell |
8
-23
| -74% | -$211 | ﹤0.01% | 3656 |
|
|
2024
Q2 | $337 | Sell |
31
-295
| -90% | -$3.78K | ﹤0.01% | 3640 |
|
|
2024
Q1 | $6.11K | Sell |
326
-10
| -3% | -$231 | ﹤0.01% | 3294 |
|
|
2023
Q4 | $7.28K | Buy |
336
+269
| +401% | +$5.33K | ﹤0.01% | 3231 |
|
|
2023
Q3 | $1.38K | Buy |
+67
| New | +$1.94K | ﹤0.01% | 3632 |
|
|
2021
Q1 | – | Sell |
-29,469
| Closed | -$2.61M | – | 2358 |
|
|
2020
Q4 | $2.61M | Buy |
29,469
+8,129
| +38% | +$599K | 0.02% | 1139 |
|
|
2020
Q3 | $1.53M | Buy |
21,340
+5,072
| +31% | +$257K | 0.01% | 1311 |
|
|
2020
Q2 | $770K | Buy |
16,268
+1,545
| +10% | +$56.1K | 0.01% | 1666 |
|
|
2020
Q1 | $561K | Buy |
14,723
+4,763
| +48% | +$276K | 0.01% | 1673 |
|
|
2019
Q4 | $666K | Buy |
9,960
+2,380
| +31% | +$293K | 0.01% | 1765 |
|
|
2019
Q3 | $1.07M | Buy |
7,580
+5,695
| +302% | +$953K | 0.01% | 1486 |
|
|
2019
Q2 | $342K | Buy |
1,885
+259
| +16% | +$44.2K | ﹤0.01% | 2024 |
|
|
2019
Q1 | $278K | Buy |
+1,626
| New | +$235K | ﹤0.01% | 2091 |
|
|
2018
Q4 | – | Sell |
-1,632
| Closed | -$200K | – | 2294 |
|
|
2018
Q3 | $200K | Sell |
1,632
-35
| -2% | -$5.4K | ﹤0.01% | 2183 |
|
|
2018
Q2 | $282K | Buy |
1,667
+211
| +14% | +$33.1K | ﹤0.01% | 2091 |
|
|
2018
Q1 | $247K | Buy |
1,456
+113
| +8% | +$19.2K | ﹤0.01% | 2128 |
|
|
2017
Q4 | $242K | Buy |
+1,343
| New | +$130K | ﹤0.01% | 2145 |
|
Other funds holding SAGE
IA
HNB
Comerica Bank's SAGE Position: Q3 2025 in Review
Comerica Bank sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 120 shares — an estimated $1.09K sold.
Comerica Bank first reported a position in SAGE in Q4 2017 and held it in 20 quarters. The position peaked at $2.61M in Q4 2020. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.
- Comerica Bank reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
- Comerica Bank sold 120 Sage Therapeutics shares in Q3 2025, an estimated $1.09K.
- Comerica Bank first reported a position in Sage Therapeutics in Q4 2017 and held it in 20 quarters.
- Comerica Bank's Sage Therapeutics position peaked at $2.61M in Q4 2020.
- 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.
Based on Comerica Bank's 13F filing for Q3 2025, filed 14 Nov 2025.